Literature DB >> 2364958

The value of local 99mTc(Sn)-MDP bone to soft tissue uptake ratio in osteoporosis, before and during fluoride therapy.

J A Raymakers1, T J Savelkoul, A Hoekstra, W J Visser, P P van Rijk, S A Duursma.   

Abstract

The reproducibility and diagnostic value of local bone to soft tissue uptake ratio of 99mTc(Sn)-MDP as a bone tracer was examined in a prospective study in 35 patients who were under investigation and/or treatment for postmenopausal osteoporosis. The ratio of tracer uptake in the second lumbar vertebra (L2) and both femoral shafts was calculated from the number of counts in suitable regions of interest. Results obtained with settings and calculations in the routine practice were compared to the results obtained by revision of all raw data in one run by one person. The results were compared to the serum alkaline phosphatase activity (AP) and to local bone mineral mass as determined by dual photon absorptiometry (DPA). In 15 patients serial measurements during fluoride therapy were also compared to serum osteocalcin values and to bone histomorphometric data. The precision error of the calculation of uptake ratios from raw counts (including selection of region of interest) was 13.9% for the femoral shaft and 14.7% for L2. The mean difference between left and right femoral shaft in individuals was not significant and its variance was small P greater than 0.1). There was a weak but significant linear correlation between local uptake ratio in the spine and AP in the total material (r = 0.328 P less than 0.01). However, changes in local uptake ratio during therapy with fluoride in 15 patients were too small to be of any value and did not correlate with changes in alkaline phosphatase or osteocalcin or trabecular surface covered with osteoblasts.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2364958     DOI: 10.1007/bf01146854

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  11 in total

1.  Quantitative structural analysis of human cancellous bone.

Authors:  W A Merz; R K Schenk
Journal:  Acta Anat (Basel)       Date:  1970

2.  Quantitative assessment of 99mTc-MDP scans in investigation of diffuse alterations in bone.

Authors:  J P Pfeifer; U Büll; H Pfeifer
Journal:  Eur J Nucl Med       Date:  1979-12

3.  Observations on computerized quantitative bone scintigraphy in renal osteodystrophy.

Authors:  P de Graaf; E K Pauwels; P H Vos; I M Schicht; J te Velde; J de Graeff
Journal:  Eur J Nucl Med       Date:  1984

4.  Skeletal scintigraphic changes in osteoporosis treated with sodium fluoride: concise communication.

Authors:  E E Schulz; C R Libanati; S M Farley; G A Kirk; D J Baylink
Journal:  J Nucl Med       Date:  1984-06       Impact factor: 10.057

5.  Monitoring fluoride therapy in osteoporosis by dual photon absorptiometry.

Authors:  J A Raymakers; C F van Dijke; A Hoekstra; S A Duursma
Journal:  Bone       Date:  1987       Impact factor: 4.398

6.  A critical assessment of bone scan quantitation (bone to soft tissue ratios) in the diagnosis of metabolic bone disease.

Authors:  I Fogelman; R G Bessent; D Gordon
Journal:  Eur J Nucl Med       Date:  1981-03

7.  The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.

Authors:  I Fogelman; R G Bessent; J G Turner; D L Citrin; I T Boyle; W R Greig
Journal:  J Nucl Med       Date:  1978-03       Impact factor: 10.057

8.  Bisphosphonate whole body retention test: relations to bone mineralization rate, renal function and bone mineral content in osteoporosis and metabolic bone disorders.

Authors:  L Mosekilde; C Hasling; P C Tågehøj Jensen; F Tågehøj Jensen
Journal:  Eur J Clin Invest       Date:  1987-12       Impact factor: 4.686

9.  Studies in skeletal tracer kinetics. V: Computer-simulated Tc-99m (Sn)MDP bone-scan changes in some systemic disorders: concise communication.

Authors:  N D Charkes; P T Makler
Journal:  J Nucl Med       Date:  1981-07       Impact factor: 10.057

10.  Deconvolution analysis of 99mTc-methylene diphosphonate kinetics in metabolic bone disease.

Authors:  J Knop; E Kröger; P Stritzke; C Schneider; H P Kruse
Journal:  Eur J Nucl Med       Date:  1981-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.